TrialArthritis & rheumatology (Hoboken, N.J.)2021

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.

Yemil Atisha-Fregoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.